shutterstock_1018258276 - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

FDA approves Kala’s Eysuvis for dry eye syndrome

Eysuvis is composed of a corticosteroid that is commonly used for DES as an off-label option. Credit: 9nong / Shutterstock.